Zenotech Laboratories Ltd (532039) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zenotech Laboratories Ltd (532039) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH81379D
  • |
  • Pages: 18
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Zenotech Laboratories Ltd (Zenotech) manufactures and markets generic biopharmaceuticals products. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company's Generic biopharmaceuticals is further sub-divided into generic biological and generic chemicals. Its product portfolio includes G-CSF, G-MCSF and generic chemical oncology injectables. The company is specialty in generic injectables in the area of manufacturing Oncology, bio-technology and General Injectables products. The company markets its products in both domestic and international markets. It has subsidiaries in Nigeria, Brazil and the US. Zenotech is headquartered in Hyderabad, Telangana, India.

Zenotech Laboratories Ltd (532039)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Equity Offering 10

Zenotech Labs to Raise Funds through Rights Offering 10

Zenotech Labs Plans to Raise up to USD17.6 Million in Rights Offering 11

Acquisition 12

Sun Pharma To Acquire 28.1% Stake In Zenotech Labs For USD 3 Million 12

Zenotech Laboratories Ltd-Key Competitors 13

Zenotech Laboratories Ltd-Key Employees 14

Zenotech Laboratories Ltd-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Recent Developments 16

Corporate Communications 16

Feb 03, 2018: Zenotech Laboratories Appoints Mr. Rajendra Singh Parihar as CEO 16

Nov 21, 2017: Zenotech Laboratories: Resignation of Chief Executive officer of the company 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18

List of Figures

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Zenotech Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Zenotech Labs to Raise Funds through Rights Offering 10

Zenotech Labs Plans to Raise up to USD17.6 Million in Rights Offering 11

Sun Pharma To Acquire 28.1% Stake In Zenotech Labs For USD 3 Million 12

Zenotech Laboratories Ltd, Key Competitors 13

Zenotech Laboratories Ltd, Key Employees 14

Zenotech Laboratories Ltd, Subsidiaries 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Zenotech Laboratories Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17245
Site License
USD 500 INR 34490
Corporate User License
USD 750 INR 51735

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com